Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Apr 16, 2022; 14(4): 215-225
Published online Apr 16, 2022. doi: 10.4253/wjge.v14.i4.215
Table 2 Comparison of endoscopic retrograde cholangiopancreatography-related complications between patients with a performance status score of 0-2 and 3-4
All patients
P valuePropensity score-matched patients
P value
Patients with a PS 0-2 (n = 1113)
Patients with a PS 3 or 4 (n = 230)
Patients with a PS 0-2 (n = 196)
Patients with a PS 3 or 4 (n = 196)
Overall complications, n (%)100 (9.0) 16 (7.0) 0.379 (4.6) 13 (6.6) 0.51
Severity of overall complications0.0630.042
Mild (%)65 (65.0) 6 (37.5) 7 (77.8) 3 (23.1)
Moderate (%)29 (29.0) 8 (50.0) 2 (22.2) 8 (61.5)
Severe (%)6 (6.0) 2 (12.5) 0 (0.0) 2 (15.4)
PEP (%)50 (4.5) 5 (2.2) 0.143 (1.5) 2 (1.0) 1.0
Severity of PEP (%)0.0340.10
Mild (%)34 (68.0) 3 (60.0) 3 (100.0) 0 (0.0)
Moderate (%)14 (28.0) 0 (0.0) 0 (0.0) 0 (0.0)
Severe (%)2 (4.0) 2 (40.0) 0 (0.0) 2 (100.0)
Bleeding (%)18 (1.6) 4 (1.7) 0.781 (0.5) 4 (2.0) 0.37
Severity of bleeding (%)0.120.40
Mild (%)12 (66.7) 1 (25.0) 1 (100.0) 1 (25.0)
Moderate (%)3 (16.7) 3 (75.0) 0 (0.0) 3 (75.0)
Severe (%)3 (16.7) 0 (0.0) 0 (0.0) 0 (0.0)
Cholangitis (%)18 (1.6) 4 (1.7) 0.783 (1.5) 4 (2.0) 1.0
Severity of cholangitis (%)0.0770.49
Mild (%)14 (77.8) 1 (25.0) 2 (66.7) 1 (25.0)
Moderate (%)4 (22.2) 3 (75.0) 1 (33.3) 3 (75.0)
Perforation (%)10 (0.9) 0 (0.0) 0.231 (0.5) 0 (0.0) 1.0
Severity of perforation (%)1.0NA
Mild (%)4 (40.0) 0 (0.0) 0 (0.0) 0 (0.0)
Moderate (%)5 (50.0) 0 (0.0) 1 (100.0) 0 (0.0)
Severe (%)1 (10.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pneumonia (%)4 (0.4) 3 (1.3) 0.101 (0.5) 3 (1.5) 0.62
Severity of aspiration pneumonia (%)1.01.0
Mild (%)1 (25.0) 1 (33.3) 1 (100.0) 1 (33.3)
Moderate (%)3 (75.0) 2 (66.7) 0 (0.0) 2 (66.7)